Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of Immune Reconstitution with Darunavir-based ART
NCT01869634Phase 4Completed
- Sponsor
- University of California, Davis
- Start
- Jun 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of darunavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by University of California, Davis. Primary endpoint: Number of CD4+ T-cells in the Lamina Propria/mm2 at 12 months. Started Jun 2013; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01869634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01869634.